Inhibitory actions of berberine on growth and arylamine N- acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients

International Journal of Toxicology

Volumn 18, Issue 1, 1998, Pages 35-40

  Chung, J G ^a   Wu, L T ^a   Chang, S H ^a   Lo, H H ^b   Hsieh, S E ^b   Li, Y C ^b   Hung, C F ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

^c JEN AI HOSPITAL   (Taiwan)

Author keywords

Berberine; Helicobacter pylori; N acetyltransferase

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; BERBERINE;

ACETYLATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DETOXIFICATION; DOSE RESPONSE; ENZYME KINETICS; GROWTH INHIBITION; HELICOBACTER PYLORI; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PEPTIC ULCER; STOMACH CANCER;

ANIMALIA; HELICOBACTER PYLORI; PROTOZOA;

EID: 21544431889     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/109158199225783     Document Type: Article

References (40)

1. Amin, A. H., T. V. Subbaiah, and K. M. Abbasi. 1959. Berberine sulfate: Anti-microbial activity, bioassay and mode of action. Can. J. Microbiol. 15:1067-1076.
2. Bell, D. A., A. F. Badawi, N. P. Lang, D. W. Ilett, F. F. Kadlubar, and A. Hirvonen. 1995. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: Association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res. 55:5226-5229.
3. Blaser, M. J., and J. Parsonnet. 1994. Parasitism by the "slow" bacterium Helicabacter pylori leads to altered homeostasis and neoplasia. J. Clin. Invest. 94:4-8.
4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
5. Cartwright, R. A., R. W. Glasham, H. J. Rogers, R. A. Ahmad, D. Barham-Hall, E. Higgins, and M. A. Kaha. 1982. The role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet 2:842-846.
6. s slow acetylator congenic mice. Drug Metab. and Dispos. 21:1057-1063.
7. Chung, J. G., H. H. Wang, M. F. Tsou, S. E. Hsien, H. H. Lo, Y. S. Yen, S. S. Chang, L. T. Wu, and J. H. Lee. 1997. Evidence for arylamine N-acetyltransferase in the bacteria Helicobacter pylori. Toxicol. Lett. 91:63-71.
8. Cleland, W. W. 1967. The statistical analysis of enzyme kinetics data. Adv. Enzymol. 29:1-30.
9. Correa, P. 1991. Is gastric carcinoma an infection disease? N. Engl. J. Med. 325:1170-1171.
10. Dixon, M. F. 1989. Campylobacter pylori and chronic gastritis. In Campylobacter pylori and gastroduodenal disease, 106-116. Oxford, UK: Blackwell Scientific Publications.
11. Einisto, P., M. Watanabe, M. Ishidate, and T. Nohmi. 1991. Mutagenicity of 30 chemicals in 5. typhimurium possessing different nitroreductase or O-acetyltransferase activities. Mutation Res. 259:95-102.
12. Evans, D. A. P. 1989. N-acetyltransferase. Pharmacol. Ther. 42:157-234.
13. Fujimura, H., T. Sawada, and N. Goto. 1960. Screening test of antiinflammatory action of the constituents of crude drugs and plants. J. Pharmacol. Soc. Japan 90:782-783.
14. Geddie, J. E., S. Amin, K. Huie, and S. S. Hecht. 1987. Formation and tumorigenicity of benzo[b]fluoranthrene metabolites in mouse epidermis. Carcinogenesis 8:1579-1584.
15. Grant, D. M., P. D. Josephy, and H. L. Lord. 1992. Salmonella typhimurium strains expressing human arylamine N-acetyltransferase: Metabolism and mutagenic activation of aromatic amines. Cancer Res. 52:3961-3964.
16. Hein, D. W., J. G. Omichinski, J. A. Brewer, and W. W. Weber. 1982a. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. J. Pharmacol. Exp. Ther. 220:8-15.
17. Hein, D. W., T. N. Smolen, R. R. Fox, and W. W. Weber. 1982b. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains. J. Pharmacol. Exp. Ther. 223:40-44.
18. Ilett, K. K., B. M. David, P. Detchon, W. M. Castledon, and R. Kwa. 1987. Acetylator phenotype in colorectal carcinoma. Cancer Res. 47:1466-1469.
19. Kato, J., S. Tominaga, and Y. Ito. 1992. A prospective study of atrophic gastritis and stomach cancer risk. Jpn. J. Cancer Res. 83:1137-1142.
20. Kimura, Y., and S. Koizumi. 1953. Studies on the standardization of crude drugs II. On the production conditions and component of crude drugs (I), on the production conditions and berberine content of Phellodendron. J. Pharmacol. Soc. Japan 73:194-195.
21. Kinouchi, T., K. Kataoka, K. Miyanishi, S. Akimoto, and Y. Ohnishi. 1993. Biological activities of the intestinal microflora in mice treated with antibiotics or untreated and the effects of the microflora on absorption and metabolic activation of orally administrated glutathione conjugates of K-region epoxides of 1-nitropyrene. Carcinogenesis 14:869-874.
22. Lang, N. P., D. Z. Chu, C. F. Hunter, D. C. Kendell, J. J. Flammang, and F. Kadlubar. 1987. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch. Surg. 121:1259-1261.
23. Larsen, G. L. 1988. Deconjugation of biliary metabolites by microfloral β-glucronidase, sulphatase and cysteine conjugate β-lyase and their subsequent enterohepatic circulation. In Role of gut flora in toxicity and cancer, ed. I. Rowland, 79-107. London: Academic Press.
24. Lewis, W. H., and M. P. F. Elvin-Lewis. 1977. Internal poisons. In Alkaloids: Chemistry and physiology, vol. 4, eds. R. H. F. Manske and H. L. Holmes, 77-118. New York: Academic Press.
25. Marshall, B. 1986. Campylobacter pylori and gastritis. J. Infect. Dis. 153:650-657.
26. Marshall, B., C. S. Goodfwin, and J. R. Warren. 1988. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Cancer Res. 2:1437-1447.
27. Minchin, R. F., P. T. Reeves, C. H. Teitel, M. E. McManus, T. Mojarrabi, K. F. Ilett, and F. F. Kadlubar. 1992. N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem. Biophys. Res. Commun. 185:839-844.
28. Mommsen, S., N. M. Barford, and J. Agaard. 1985. N-acetyltransferase phenotypes in the urinary bladder carcinogenesis of a low-risk population. Carcinogenesis 6:199-201.
29. Nishino, H., K. Kitagawa, H. Fujiki, and A. Iwashima. 1986. Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin. Oncology 43:131-134.
30. Okumura, F., O. Ueda, S. Kitamuru, and K. Tatsumi. 1995. N-acetylation and N-formation of carcinogenic arylamine and related compounds in dogs. Carcinogenesis 16:71-76.
31. Parsonnet, J., C. D. Friedman, and D. P. Vandersteen. 1991. Helicobacter pylon infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131.
32. Rabbani, G. H., J. Butler, J. Knight, S. C. Sanyal, K. Alam. 1987. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J. Infect. Dis. 155:979-984.
33. Rauws, E. A. J., W. Langenberg, and H. J. Houthaff. 1988. Camplobacter pylori associated chronic active antral gastritis: A prospective study of its prevalence and the effects of antibacterial and antiucler treatment. Gastroenterol. 94:33-40.
34. Tang, W., and G. Eisenbrand. 1992. In Chinese drugs of plant origin, 361-371. London: Springer.
35. Tannen, R. H., and W. W. Weber. 1980. Inheritance of acetylator phenotype in mice. J. Pharmacol. Exp. Ther. 213:480-484.
36. Tokiwa, H., and Y. Ohnishi. 1986. Mutagenicity and carcinogenicity of nitroarenes and their sources in the environment. CRC. Crit. Rev. Toxicol. 17:23-86.
37. Wang, H. H., and J. G. Chung. 1997. Emodin-induced inhibition of growth and DNA damage in the Helicobacter pylori. Curr. Microbiol. 35:262-266.
38. Warren, J. R., and B. J. Marshall. 1983. Unidentifield curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273-1275.
39. 69 residue in the catalytic mechanism of N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium: Sequence similarity at the amino acid level suggests a common catalytic mechanism of acetyltransferase for S. typhimurium and higher organisms. J. Biol. Chem. 267:8429-8436.
40. Weber, W. W., and D. W. Hein. 1985. N-acetylation pharmacogenetics. Pharm. Rev. 37:25-79.